CYL3007 | PrecisION™ hKCNQ1/hminK-CHO Recombinant Stable Cell Line

CYL3007
2 mL  2 x 1 ml aliquots
Recuperando precio...
No pudo obtenerse el precio
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmar Disponibilidad a confirmar
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
      Se avisará

       

      Póngase en contacto con el Servicio de Atención al Cliente

         CompararClick To Print This Page

      Overview

      Replacement Information

      Tabla espec. clave

      Notas de aplicación Especie Células hospedadoras Blanco proteico
      CHO-K1 cells stably expressing human KCNQ1 and human minK were analysed by patch-clamp and IonWorks. Over 80% of cells expressed >500 pA outward current (n=3180) with a mean current amplitude of 1050 pA. KvLQT1/minK currents were inhibited by standard blockers such as clotrimazole (pIC50 = 5.3±0.1; n=4) and linopirdine (pIC50 5.1±0.1; n=4).HumanChinese Hamster Ovarian K-1 cells (CHO K-1)hKCNQ1/hminK
      Descripción
      Número de catálogo CYL3007
      Marca de familia Upstate
      Sinónimos LQT1 KCNQ1 JLNS1 ATFB1 SQT2 KCNA8 LQT WRS Kv1.9 KVLQT1 RWS Kv7.1 KCNA9 LQTS FLJ26167
      Nombre comercial
      • Upstate
      • PrecisION
      Descripción PrecisION™ hKCNQ1/hminK-CHO Recombinant Stable Cell Line
      Visión de conjunto Recombinant CHO-K1 cell line co-expressing the human KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) and human minK (delayed rectifier potassium channel).

      Format:
      2 x 1 ml aliquots containing 180x 106cells/ml in 10% DMSO at passage 16.
      Información preliminar KCNQ1 and mink form the slow delayed rectifier potassium current, IKs in the heart. This multimeric ion channel contributes to cardiac action potential repolarization and determines the heartbeat rate. Mutations in either KCNQ1 or minK that reduce IKs have been shown to cause long-QT syndrome (LQTS), a disorder of ventricular repolarization that can result in cardiac arrhythmia and sudden death. A well-recognized potential treatment for LQTS caused by reduction of IKs is to enhance functional activation of cardiac KCNQ1/minK channels.
      Referencias bibliográficas
      Información del producto
      Componentes
      • Pack contains 2 vials of mycoplasma-free cells, 1 ml per vial
      Presentación 2 x 1 ml aliquots
      Aplicaciones
      Aplicación Human KCNQ1/minK ion channel stably expressed in CHO cells for use in electrophysiological assays.
      Notas de aplicación CHO-K1 cells stably expressing human KCNQ1 and human minK were analysed by patch-clamp and IonWorks. Over 80% of cells expressed >500 pA outward current (n=3180) with a mean current amplitude of 1050 pA. KvLQT1/minK currents were inhibited by standard blockers such as clotrimazole (pIC50 = 5.3±0.1; n=4) and linopirdine (pIC50 5.1±0.1; n=4).
      Información biológica
      Especie Human
      Número de Entrez Gene
      Resumen de Entrez Gene This gene encodes a protein for a voltage-gated potassium channel required for the repolarization phase of the cardiac action potential. The gene product can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome, Romano-Ward syndrome, Jervell and Lange-Nielsen syndrome and familial atrial fibrillation. The gene is located in a region of chromosome 11 that contains a large number of contiguous genes that are abnormally imprinted in cancer and the Beckwith-Wiedemann syndrome. Two alternative transcripts encoding distinct isoforms have been described.
      Símbolo de gen
      • LQT1
      • KCNQ1
      • JLNS1
      • ATFB1
      • SQT2
      • KCNA8
      • LQT
      • WRS
      • Kv1.9
      • KVLQT1
      • RWS
      • Kv7.1
      • KCNA9
      • LQTS
      • FLJ26167
      Células hospedadoras Chinese Hamster Ovarian K-1 cells (CHO K-1)
      Blanco proteico hKCNQ1/hminK
      Subfamilia seleccionada Potassium
      Número UniProt
      Resumen UniProt FUNCTION: SwissProt: P51787 # Probably important in cardiac repolarization. Associates with KCNE1 (MinK) to form the I(Ks) cardiac potassium current. Elicits a rapidly activating, potassium-selective outward current. Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current in CHO cells in which cloned KCNQ1/KCNE1 channels were coexpressed with M1 muscarinic receptors. May associate also with KCNE3 (MiRP2) to form the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions, which is reduced in cystic fibrosis and pathologically stimulated in cholera and other forms of secretory diarrhea.
      SIZE: 676 amino acids; 74699 Da
      SUBUNIT: Heteromultimer with KCNE1 (MinK) or KCNE3 (MiRP2).
      SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
      TISSUE SPECIFICITY: Abundantly expressed in heart, pancreas, prostate, kidney, small intestine and peripheral blood leukocytes. Less abundant in placenta, lung, spleen, colon, thymus, testis and ovaries.
      DOMAIN: SwissProt: P51787 The segment S4 is probably the voltage-sensor and is characterized by a series of positively charged amino acids at every third position.
      DISEASE: SwissProt: P51787 # Defects in KCNQ1 are the cause of long QT syndrome type 1 (LQT1) [MIM:192500]; also known as Romano-Ward syndrome (RWS). Long QT syndromes are heart disorders characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress. LQT1 inheritance is an autosomal dominant. & Defects in KCNQ1 are a cause of Jervell and Lange-Nielsen syndrome (JLNS) [MIM:220400]. JLNS is an autosomal recessive cardio-auditory syndrome characterized by a prolonged QT interval in the electrocardiogram and congenital deafness. & Defects in KCNQ1 are the cause of atrial fibrillation type 1 (ATFB1) [MIM:607554]. ATFB is characterized by rapid and irregular activation of the atrium. ATFB causes thromboembolism, tachycardia-mediated cardiomyopathy, heart failure and ventricular arrhythmia. & Defects in KCNQ1 are the cause of short QT syndrome type 2 (SQT2) [MIM:609621]. Short QT syndromes are heart disorders characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. They cause syncope and sudden death.
      SIMILARITY: Belongs to the potassium channel family. KQT subfamily.
      MISCELLANEOUS: Mutagenesis experiments were carried out by expressing in Xenopus oocytes or COS-7 cells KCNQ1 mutants either individually (homomultimers) or in combination with both wild-type KCNQ1 (mut/wt homomultimers) and minK (heteromultimers).
      Tipo de línea celular
      • Ion Channel Cell Lines
      Información fisicoquímica
      Dimensiones
      Información de materiales
      Información toxicológica
      Información de seguridad según el GHS
      Información de seguridad
      Declaraciones de uso del producto
      Aseguramiento de calidad Mycoplasma Testing:
      The cell line has been screened to confirm the absence of Mycoplasma species
      Declaración de uso
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      • This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges Merck-Millipore to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
      Información de almacenamiento y transporte
      Información sobre embalaje
      Cantitad 2 mL
      Envase 2 x 1 ml aliquots
      Información de transporte
      Información complementaria
      Especificaciones

      Productos y aplicaciones relacionados

      Familias de productos

      Productos relacionados por: Brand Facette

      Categorías

      Life Science Research > Cell Culture and Systems > Cell Lines > Ion Channel Cell Lines
      Life Science Research > Drug Discovery and Development > Ion Channel Cell Lines & Assays > Ion Channel Cell Lines